Treatment of multiple superficial papillary tumors of the bladder by intracavitary yttrium-90.
Intravesical Y-90 was used in 38 patients with multiple papillary T1 tumors considered beyond control by cystodiathermy. Of the 32 patients available for 3-year observation 19 (60 per cent) were alive after 3 years, 6 had died of progression of the tumor and 7 had died of other causes. Prolonged imporvement was noted in 23 patients (72 per cent). The complication rate was moderate and only 2 patients required cystectomy for symptoms caused by radiation damage alone.
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000532:radiotherapy*; D010212:Papilloma / Q000401:mortality / Q000532:radiotherapy*; D011832:Radiation Injuries; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D015020:Yttrium Isotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D015020:Yttrium Isotopes